Brief: G1 Therapeutics Q2 Basic EPS USD 0.17
02/08/2023 11:33
Aug 2 (Reuters) - G1 Therapeutics Q2 operating expenses USD 30.876 million. * Q2 net income USD 8.71 million * Q2 revenue USD 11,091 million vs. IBES estimate USD 28.9 million * Q2 basic EPS USD 0.17
Recent news on G1 Therapeutics
See all newsG1 Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Ralph Lauren, Illumina, Disney
U.S. STOCKS ON THE MOVE-Walt Disney, SpringWorks, Shopify